OREANDA-NEWS. PSI CRO, a full-service contract research organization focused on on-time clinical trial delivery, will be sponsoring and attending the upcoming Clinical Operations in Oncology East Coast 2015 conference on July 15th -16th in Boston, MA.

PSI‘s Feasibility specialist Dr. Veronika Fekete will present on clinical trial feasibility at 09:00 am on Day 1. She will share approaches to patient recruitment and retention, which are at the core of PSI’s operational strengths, discussing why thorough, multifunctional feasibility assessments are vital for successful clinical trial planning, as well as presenting case studies of global clinical trials delivered on time across a wide range of oncology indications.

PSI staff will be also available for consultation and discussions regarding PSI’s success in on-time planning and delivery of global clinical trials in oncology and other therapeutic areas.

PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug, Switzerland at 113a Baarerstrasse 6300.